House panel: No ban on ads for new drugs

A House subcommittee approved a package of bills to overhaul drug safety oversight laws, but removed a provision that would have let the FDA impose a three-year ban on direct-to-consumer ads for newly launched drugs. Instead, the bill would allow the FDA to fine companies $250,000 for showing false or misleading ads to consumers.

View Full Article in:

Reuters · Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Media

Job Title Company Location
Director, Digital Research (Burbank or New York)
Warner Bros. Entertainment Inc.
Burbank, CA
Data Entry and Integrity Coordinator
Interactive Advertising Bureau
New York, NY
Director of Business Development - Denver/New York
Denver, CO
Director of Marketing - Denver
Denver, CO
Instructor, eMarketing
Charlottesville, VA